Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(30%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
7
70%
Ph phase_4
3
30%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 4Post-market surveillance
3(30.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(6)
Completed(3)
Other(1)

Detailed Status

Not yet recruiting3
Completed3
Recruiting2
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (30.0%)
N/A7 (70.0%)

Trials by Status

unknown110%
not_yet_recruiting330%
recruiting220%
active_not_recruiting110%
completed330%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10